How will AI really change pharma? Medical affairs speaks out
Insight into how medical affairs leaders are navigating the potential of AI amid vast amounts of data and unstoppable timelines.
Creating a culture based on insights: challenges, solutions, the how and why
Prioritizing insights can help medical affairs teams rethink how they position themselves in the broader organization
The insight gap is pharma’s most expensive problem. What’s the solution?
Forging ahead without needed insights wastes time, money, and opportunity. How can pharma teams close the insight gap?
Why should I use social monitoring for medical congresses?
You may be using social monitoring year-round, but there’s value in targeting a specific congress.
Are you getting what you need from patients, specialists, and other key players?
Better decisions begin with a more complete view of stakeholder input.
Got agility? Faster insights reporting is a game-changer for pharma execs
Pharma teams need to accelerate how they analyze and share information within the organization.
Too many channels? Not enough data? How medical affairs can solve its silo problem
Is your insights management strategy ‘just right’?
Congress strategic planning for the year ahead
You think about congress planning all year long – shouldn’t your tools and technology work on the same schedule?
Which medical affairs activities are most labor-intensive when engaging external advisors?
Pharma teams know where they work the hardest, but do they know the hidden costs?
Top ten: our most popular posts and resources
Catch up on the industry’s most-read articles and resources from 2023.